US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avid Bioservices, Inc.

12.49

0.0000

Volume:- -

Turnover:38.32M

Market Cap:798.90M

PE:-5.22

High:12.49

Open:12.49

Low:12.49

Close:12.49

52wk High:12.51

52wk Low:5.90

Shares:63.96M

Float Shares:50.62M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3946

EPS(LYR):-2.2271

ROE:-133.29%

ROA:-3.27%

PB:17.83

PE(LYR):-5.61

Loading ...

Overview Company News Filings

Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET

Full year Trading Update and Notice of Results

Morepen Laboratories Secures INR8.25 Billion CDMO Mandate; Shares Jump 13%

MT Newswires Live

Morepen Labs Wins ₹825 Crore Global CDMO Mandate to Scale Manufacturing Platform

Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent

Press Release: Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

Press Release: Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm

Goldman Sachs: Mainland Healthcare Sector Returns to Hinge on Data and Earnings Visibility This Year, CDMO Firms Favored

Bora Pharmaceuticals Unit to Buy CDMO Operational Assets for $18 Million

MT Newswires Live

Press Release: Piramal Pharma Limited Announces Results for Q3 and 9M FY26

NARMAFOTINIB Large-Scale Manufactre Complete

Press Release: Samsung Biologics reports fourth quarter and fiscal year 2025 financial results

Press Release: Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Strong Earnings and Acquisition of TOT Biopharm Bolster WUXI XDC's (02268) Position in ADC CDMO Market

Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting

CLSA: WUXI APPTEC (02359) Top Pick in China's Pharma CRO/CDMO Sector, Expected to Outperform Peers This Year

Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program

Nutriband CEO Publishes Letter to Shareholders

MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CDMO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDMO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":12.49,"timestamp":1738702800000,"preClose":12.49,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":50623090,"shares":63963302,"eps":-2.394638,"marketStatus":"Halted","change":0,"latestTime":"02-04 16:00:00 EST","open":12.49,"high":12.49,"low":12.49,"amount":38317107.960278,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.394638,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":12.49,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","floatShares":50623090,"roa":"-3.27%","roe":"-133.29%","lyrEps":-2.227139,"shares":63963302,"dividePrice":0,"high":12.49,"amplitude":0,"preClose":12.49,"low":12.49,"week52Low":5.9,"pbRate":"17.83","psRate":"5.31","week52High":12.51,"institutionHeld":0.9807,"latestPrice":12.49,"eps":-2.394638,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.394638,"open":12.49,"prevYearClose":12.35,"prevWeekClose":12.48,"prevMonthClose":12.48,"prevQuarterClose":12.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDMO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"CDMO","reason":null,"defaultRemindTime":1738852200000,"announcedDate":"2025-02-04","type":"delisting","dateTimestamp":1738818000000},{"market":"US","date":"2024-12-10","symbol":"CDMO","fiscalQuarterEnding":"2024/10","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1733806800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-09-09","symbol":"CDMO","fiscalQuarterEnding":"2024/07","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1725854400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-07-02","symbol":"CDMO","fiscalQuarterEnding":"2024/04","expectedEps":0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1719892800000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-04-24","symbol":"CDMO","fiscalQuarterEnding":"2024/01","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDMO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDMO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733374800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CDMO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CDMO","date":"2025-02-04","current":-5.21582,"percent":0.349064,"low":-236.80087,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"high":9284.394324,"avg":397.880667,"sd":1431.818994,"marketCap":798262008},"quantilePoints":[{"date":"2021-04-01","current":262.001423,"twenty":-77.278436,"median":-6.698376,"eighty":-1.907206,"marketCap":1166692337},{"date":"2021-04-09","current":264.870052,"twenty":-77.30512,"median":-6.716829,"eighty":-1.906724,"marketCap":1179466340},{"date":"2021-04-16","current":261.72822,"twenty":-77.30512,"median":-6.716829,"eighty":-1.903436,"marketCap":1165475765},{"date":"2021-04-23","current":289.594899,"twenty":-77.30512,"median":-6.716829,"eighty":-1.897813,"marketCap":1289566086},{"date":"2021-04-30","current":292.395227,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1302035947},{"date":"2021-05-07","current":277.300776,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1234820356},{"date":"2021-05-14","current":274.432148,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1222046353},{"date":"2021-05-21","current":274.295546,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888362,"marketCap":1221438067},{"date":"2021-05-28","current":290.68771,"twenty":-77.30512,"median":-6.716829,"eighty":-1.871961,"marketCap":1294432373},{"date":"2021-06-04","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.85901,"marketCap":1407573549},{"date":"2021-06-11","current":315.68576,"twenty":-77.30512,"median":-6.716829,"eighty":-1.848648,"marketCap":1405748691},{"date":"2021-06-18","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.841619,"marketCap":1407573549},{"date":"2021-06-25","current":342.869433,"twenty":-77.30512,"median":-6.716829,"eighty":-1.832157,"marketCap":1526797583},{"date":"2021-07-02","current":142.499473,"twenty":-77.30512,"median":-6.716829,"eighty":-1.830139,"marketCap":1597704096},{"date":"2021-07-09","current":141.845556,"twenty":-77.30512,"median":-6.716829,"eighty":-1.821934,"marketCap":1590372376},{"date":"2021-07-16","current":136.83219,"twenty":-77.30512,"median":-6.716829,"eighty":-1.81215,"marketCap":1534162518},{"date":"2021-07-23","current":141.355118,"twenty":-77.30512,"median":-6.716829,"eighty":-1.799525,"marketCap":1584873585},{"date":"2021-07-30","current":139.774818,"twenty":-77.30512,"median":-6.716829,"eighty":-1.785372,"marketCap":1567155261},{"date":"2021-08-06","current":141.73657,"twenty":-77.30512,"median":-6.716829,"eighty":-1.764864,"marketCap":1589150422},{"date":"2021-08-13","current":136.723204,"twenty":-77.30512,"median":-6.716829,"eighty":-1.688839,"marketCap":1532940565},{"date":"2021-08-20","current":135.142904,"twenty":-77.30512,"median":-6.716829,"eighty":-1.617566,"marketCap":1515222240},{"date":"2021-08-27","current":132.180722,"twenty":-77.30512,"median":-6.716829,"eighty":-1.602452,"marketCap":1482010253},{"date":"2021-09-03","current":126.490823,"twenty":-77.30512,"median":-6.716829,"eighty":-1.594862,"marketCap":1418215110},{"date":"2021-09-10","current":101.036419,"twenty":-77.30512,"median":-6.716829,"eighty":-1.573195,"marketCap":1291851653},{"date":"2021-09-17","current":100.652615,"twenty":-77.30512,"median":-6.716829,"eighty":-1.534217,"marketCap":1286944334},{"date":"2021-09-24","current":105.881945,"twenty":-77.30512,"median":-6.716829,"eighty":-1.523573,"marketCap":1353806551},{"date":"2021-10-01","current":101.180345,"twenty":-77.30512,"median":-6.716829,"eighty":-1.517157,"marketCap":1293691897},{"date":"2021-10-08","current":108.088819,"twenty":-77.30512,"median":-6.716829,"eighty":-1.495908,"marketCap":1382023634},{"date":"2021-10-15","current":123.728834,"twenty":-77.30512,"median":-6.716829,"eighty":-1.484858,"marketCap":1581996872},{"date":"2021-10-22","current":124.73632,"twenty":-77.30512,"median":-6.716829,"eighty":-1.475257,"marketCap":1594878584},{"date":"2021-10-29","current":147.188857,"twenty":-77.30512,"median":-6.716829,"eighty":-1.460883,"marketCap":1881956729},{"date":"2021-11-05","current":163.980285,"twenty":-77.30512,"median":-6.716829,"eighty":-1.456578,"marketCap":2096651923},{"date":"2021-11-12","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.445734,"marketCap":2067208010},{"date":"2021-11-19","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.434782,"marketCap":2067208010},{"date":"2021-11-26","current":150.930947,"twenty":-77.30512,"median":-6.716829,"eighty":-1.432053,"marketCap":1929803086},{"date":"2021-12-03","current":138.697192,"twenty":-77.30512,"median":-6.716829,"eighty":92.966939,"marketCap":1773382302},{"date":"2021-12-10","current":116.804545,"twenty":-77.30512,"median":-6.716829,"eighty":99.366871,"marketCap":1638066942},{"date":"2021-12-17","current":114.169856,"twenty":-77.30512,"median":-6.716829,"eighty":101.093989,"marketCap":1601118064},{"date":"2021-12-23","current":129.714521,"twenty":-77.30512,"median":-6.716829,"eighty":102.54285,"marketCap":1819116446},{"date":"2021-12-31","current":128.133708,"twenty":-77.30512,"median":-6.716829,"eighty":106.764695,"marketCap":1796947119},{"date":"2022-01-07","current":97.527404,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1367724315},{"date":"2022-01-14","current":92.08238,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1291363300},{"date":"2022-01-21","current":79.918899,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1120782644},{"date":"2022-01-28","current":76.537715,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1073364917},{"date":"2022-02-04","current":85.056543,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192832957},{"date":"2022-02-11","current":93.180167,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1306758666},{"date":"2022-02-18","current":85.012631,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192217143},{"date":"2022-02-25","current":88.876842,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1246408831},{"date":"2022-03-04","current":81.148421,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1138025454},{"date":"2022-03-11","current":81.564879,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1147210023},{"date":"2022-03-18","current":96.139443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1352201265},{"date":"2022-03-25","current":94.690766,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1331825629},{"date":"2022-04-01","current":94.602968,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1330590742},{"date":"2022-04-08","current":83.057455,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1168203102},{"date":"2022-04-14","current":80.379598,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1130539048},{"date":"2022-04-22","current":75.418979,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1060767933},{"date":"2022-04-29","current":59.088443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":831078951},{"date":"2022-05-06","current":55.444802,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":779831140},{"date":"2022-05-13","current":54.96191,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":773039262},{"date":"2022-05-20","current":55.5765,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":781683471},{"date":"2022-05-27","current":60.449321,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":850219699},{"date":"2022-06-03","current":58.868947,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":827991733},{"date":"2022-06-10","current":55.620399,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":782300914},{"date":"2022-06-17","current":58.561652,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":823669629},{"date":"2022-06-24","current":68.52679,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":963829303},{"date":"2022-07-01","current":7.424698,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":947926104},{"date":"2022-07-08","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-15","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-22","current":8.48537,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1083344119},{"date":"2022-07-29","current":9.516981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1215052051},{"date":"2022-08-05","current":9.376527,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1197119985},{"date":"2022-08-12","current":9.536354,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1217525439},{"date":"2022-08-19","current":8.950321,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1142705440},{"date":"2022-08-26","current":8.930948,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1140232052},{"date":"2022-09-02","current":7.824981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":999030985},{"date":"2022-09-09","current":9.269592,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1139529431},{"date":"2022-09-16","current":8.637459,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1061820114},{"date":"2022-09-23","current":9.077423,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1115905799},{"date":"2022-09-30","current":9.669099,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1188641720},{"date":"2022-10-07","current":9.107766,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119635846},{"date":"2022-10-14","current":8.925711,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1097255563},{"date":"2022-10-21","current":7.868786,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":967325584},{"date":"2022-10-28","current":8.971225,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1102850633},{"date":"2022-11-04","current":6.928173,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851694119},{"date":"2022-11-11","current":7.767645,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":954892093},{"date":"2022-11-18","current":7.236653,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":889616266},{"date":"2022-11-25","current":7.438936,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":914483248},{"date":"2022-12-02","current":8.298636,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1020167920},{"date":"2022-12-09","current":6.812962,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":805660063},{"date":"2022-12-16","current":7.287183,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":861738490},{"date":"2022-12-23","current":7.202877,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851768992},{"date":"2022-12-30","current":7.255568,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":857999928},{"date":"2023-01-06","current":7.740326,"twenty":-77.30512,"median":-6.679923,"eighty":109.283255,"marketCap":915324542},{"date":"2023-01-13","current":8.593922,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1016265710},{"date":"2023-01-20","current":8.66769,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1024989021},{"date":"2023-01-27","current":8.636075,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1021250459},{"date":"2023-02-03","current":8.530693,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1008788586},{"date":"2023-02-10","current":8.699305,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1028727583},{"date":"2023-02-17","current":8.720381,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1031219957},{"date":"2023-02-24","current":8.620268,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1019381178},{"date":"2023-03-03","current":9.015451,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1066113200},{"date":"2023-03-10","current":7.350412,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":869215613},{"date":"2023-03-17","current":9.559254,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1113337596},{"date":"2023-03-24","current":9.382032,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1092697068},{"date":"2023-03-31","current":10.074809,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1173382770},{"date":"2023-04-06","current":10.203698,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1188394064},{"date":"2023-04-14","current":11.240179,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1309109882},{"date":"2023-04-21","current":10.289624,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1198401592},{"date":"2023-04-28","current":9.50555,"twenty":-77.30512,"median":-6.513848,"eighty":109.283255,"marketCap":1107082891},{"date":"2023-05-05","current":9.919068,"twenty":-77.30512,"median":-6.458489,"eighty":109.283255,"marketCap":1155244124},{"date":"2023-05-10","current":9.731105,"twenty":-77.30512,"median":-6.403131,"eighty":109.283255,"marketCap":1133352654},{"date":"2023-05-19","current":7.835366,"twenty":-77.358489,"median":-6.20015,"eighty":109.446474,"marketCap":912561547},{"date":"2023-05-26","current":8.168329,"twenty":-77.358489,"median":-6.107885,"eighty":109.446474,"marketCap":951340721},{"date":"2023-06-02","current":8.367032,"twenty":-77.358489,"median":-6.034074,"eighty":109.446474,"marketCap":974483132},{"date":"2023-06-09","current":9.194069,"twenty":-77.358489,"median":6.812962,"eighty":109.446474,"marketCap":1070805598},{"date":"2023-06-16","current":9.118884,"twenty":-77.385174,"median":6.991758,"eighty":109.528084,"marketCap":1062049010},{"date":"2023-06-23","current":1539.104598,"twenty":-77.386973,"median":7.174145,"eighty":110.625618,"marketCap":861898575},{"date":"2023-06-30","current":1496.538387,"twenty":-77.387872,"median":7.239761,"eighty":113.886744,"marketCap":838061497},{"date":"2023-07-07","current":1540.224762,"twenty":-77.387872,"median":7.287183,"eighty":118.166944,"marketCap":862525867},{"date":"2023-07-14","current":1497.65855,"twenty":-77.387872,"median":7.366219,"eighty":123.628937,"marketCap":838688788},{"date":"2023-07-21","current":1453.972175,"twenty":-77.387872,"median":7.424698,"eighty":125.174074,"marketCap":814224418},{"date":"2023-07-28","current":1438.289888,"twenty":-77.387872,"median":7.44905,"eighty":127.470924,"marketCap":805442337},{"date":"2023-08-04","current":1365.479263,"twenty":-77.387872,"median":7.624406,"eighty":129.89895,"marketCap":764668387},{"date":"2023-08-11","current":1437.169723,"twenty":-77.387872,"median":7.767645,"eighty":131.557258,"marketCap":804815045},{"date":"2023-08-18","current":1394.603513,"twenty":-77.387872,"median":7.840439,"eighty":132.799398,"marketCap":780977967},{"date":"2023-08-25","current":1319.552561,"twenty":-77.387872,"median":7.919356,"eighty":135.055715,"marketCap":738949434},{"date":"2023-09-01","current":1329.87968,"twenty":-77.387872,"median":8.066292,"eighty":136.461637,"marketCap":744732621},{"date":"2023-09-08","current":-236.80087,"twenty":-77.627134,"median":8.093067,"eighty":136.864886,"marketCap":733372293},{"date":"2023-09-15","current":-215.810775,"twenty":-79.724891,"median":8.093067,"eighty":136.864886,"marketCap":668365971},{"date":"2023-09-22","current":-193.597957,"twenty":-81.00567,"median":8.093067,"eighty":136.864886,"marketCap":599572873},{"date":"2023-09-29","current":-198.081278,"twenty":-81.501661,"median":8.093067,"eighty":136.864886,"marketCap":613457718},{"date":"2023-10-06","current":-191.356296,"twenty":-82.284183,"median":8.093067,"eighty":136.864886,"marketCap":592630450},{"date":"2023-10-13","current":-167.309392,"twenty":-83.104206,"median":8.093067,"eighty":136.864886,"marketCap":518157188},{"date":"2023-10-20","current":-142.039764,"twenty":-83.374176,"median":8.093067,"eighty":136.864886,"marketCap":439897149},{"date":"2023-10-27","current":-132.257973,"twenty":-83.539844,"median":8.114625,"eighty":137.082858,"marketCap":409602941},{"date":"2023-11-03","current":-125.125416,"twenty":-83.933555,"median":8.114625,"eighty":137.082858,"marketCap":387513414},{"date":"2023-11-10","current":-107.599706,"twenty":-84.748881,"median":8.114625,"eighty":137.082858,"marketCap":333236291},{"date":"2023-11-17","current":-105.561833,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":326924998},{"date":"2023-11-24","current":-111.87924,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":346490007},{"date":"2023-12-01","current":-103.727747,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":321244834},{"date":"2023-12-08","current":-29.21466,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":334507860},{"date":"2023-12-15","current":-32.03385,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":366787580},{"date":"2023-12-22","current":-35.402927,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":405363515},{"date":"2023-12-29","current":-37.501697,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":429394426},{"date":"2024-01-05","current":-33.911696,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":388288921},{"date":"2024-01-12","current":-37.336004,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":427497248},{"date":"2024-01-19","current":-33.746004,"twenty":-87.127444,"median":8.138341,"eighty":137.475209,"marketCap":386391744},{"date":"2024-01-26","current":-38.219697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":437615526},{"date":"2024-02-02","current":-36.397081,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":416746578},{"date":"2024-02-09","current":-36.562773,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":418643755},{"date":"2024-02-16","current":-42.527697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":486942132},{"date":"2024-02-23","current":-44.12939,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":505281511},{"date":"2024-03-01","current":-42.417236,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":485677347},{"date":"2024-03-08","current":-33.690773,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":385759351},{"date":"2024-03-15","current":-33.635542,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":385126959},{"date":"2024-03-22","current":-37.943543,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":434453565},{"date":"2024-03-28","current":-38.551081,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":441409881},{"date":"2024-04-05","current":-35.016312,"twenty":-84.693001,"median":8.125366,"eighty":137.279033,"marketCap":400936768},{"date":"2024-04-12","current":-38.109235,"twenty":-83.840428,"median":8.125366,"eighty":137.279033,"marketCap":436350742},{"date":"2024-04-19","current":-36.010466,"twenty":-83.520355,"median":8.125366,"eighty":137.279033,"marketCap":412319831},{"date":"2024-04-26","current":-26.277899,"twenty":-83.301704,"median":8.114625,"eighty":137.082858,"marketCap":464672092},{"date":"2024-05-03","current":-29.436991,"twenty":-82.558967,"median":8.114625,"eighty":137.082858,"marketCap":520534310},{"date":"2024-05-10","current":-29.221598,"twenty":-82.027926,"median":8.114625,"eighty":137.082858,"marketCap":516725523},{"date":"2024-05-17","current":-33.026868,"twenty":-81.364604,"median":8.114625,"eighty":137.082858,"marketCap":584014104},{"date":"2024-05-24","current":-31.698613,"twenty":-80.745541,"median":8.114625,"eighty":137.082858,"marketCap":560526581},{"date":"2024-05-31","current":-28.539522,"twenty":-79.544946,"median":8.114625,"eighty":137.082858,"marketCap":504664362},{"date":"2024-06-07","current":-28.826712,"twenty":-77.386073,"median":8.114625,"eighty":137.082858,"marketCap":509742745},{"date":"2024-06-14","current":-24.770151,"twenty":-75.623994,"median":8.125366,"eighty":137.279033,"marketCap":438010578},{"date":"2024-06-21","current":-24.447062,"twenty":-74.423568,"median":8.138341,"eighty":137.475209,"marketCap":432297397},{"date":"2024-06-28","current":-25.165037,"twenty":-73.302439,"median":8.168329,"eighty":137.998343,"marketCap":444993355},{"date":"2024-07-05","current":-3.47825,"twenty":-72.208373,"median":8.168329,"eighty":137.998343,"marketCap":489574115},{"date":"2024-07-12","current":-3.613766,"twenty":-71.674682,"median":8.168329,"eighty":137.998343,"marketCap":508648432},{"date":"2024-07-15","current":-3.758317,"twenty":-71.647997,"median":8.168329,"eighty":137.998343,"marketCap":528994369},{"date":"2024-08-02","current":-4.729516,"twenty":-70.687354,"median":8.235305,"eighty":139.297726,"marketCap":665693635},{"date":"2024-08-09","current":-4.774689,"twenty":-70.233717,"median":8.235305,"eighty":139.297726,"marketCap":672051740},{"date":"2024-08-16","current":-4.824378,"twenty":-69.886817,"median":8.235305,"eighty":139.297726,"marketCap":679045656},{"date":"2024-08-23","current":-4.810826,"twenty":-69.379811,"median":8.235305,"eighty":139.297726,"marketCap":677138225},{"date":"2024-08-30","current":-4.695582,"twenty":-68.84612,"median":8.235305,"eighty":139.297726,"marketCap":660917318},{"date":"2024-09-06","current":-4.079174,"twenty":-68.285745,"median":8.235305,"eighty":139.297726,"marketCap":574155972},{"date":"2024-09-13","current":-4.938462,"twenty":-67.912161,"median":8.235305,"eighty":139.297726,"marketCap":711953405},{"date":"2024-09-20","current":-5.509306,"twenty":-66.964853,"median":8.235305,"eighty":139.297726,"marketCap":794249094},{"date":"2024-09-27","current":-4.942887,"twenty":-65.87829,"median":8.235305,"eighty":139.297726,"marketCap":712591356},{"date":"2024-10-04","current":-4.672953,"twenty":-64.235019,"median":8.235305,"eighty":139.297726,"marketCap":673676340},{"date":"2024-10-11","current":-4.500373,"twenty":-63.139506,"median":8.235305,"eighty":139.297726,"marketCap":648796248},{"date":"2024-10-18","current":-4.491523,"twenty":-61.770113,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-10-25","current":-4.518073,"twenty":-60.358586,"median":8.235305,"eighty":139.297726,"marketCap":651348052},{"date":"2024-10-31","current":-4.491523,"twenty":-59.28414,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-11-08","current":-5.416378,"twenty":-57.72514,"median":8.243207,"eighty":139.447859,"marketCap":780852121},{"date":"2024-11-15","current":-5.292495,"twenty":-55.723721,"median":8.243207,"eighty":139.447859,"marketCap":762992503},{"date":"2024-11-22","current":-5.434456,"twenty":-53.82764,"median":8.243207,"eighty":139.447859,"marketCap":783458354},{"date":"2024-11-29","current":-5.447765,"twenty":-50.035478,"median":8.243207,"eighty":139.447859,"marketCap":785377027},{"date":"2024-12-06","current":-5.452201,"twenty":-48.666086,"median":8.243207,"eighty":139.447859,"marketCap":786016585},{"date":"2024-12-13","current":-5.178482,"twenty":-47.296694,"median":8.243207,"eighty":139.447859,"marketCap":787388247},{"date":"2024-12-20","current":-5.186896,"twenty":-46.111834,"median":8.243207,"eighty":139.447859,"marketCap":788667513},{"date":"2024-12-27","current":-5.165862,"twenty":-45.841544,"median":8.243207,"eighty":139.447859,"marketCap":785469348},{"date":"2025-01-03","current":-5.182689,"twenty":-45.510159,"median":8.243207,"eighty":139.447859,"marketCap":788027880},{"date":"2025-01-10","current":-5.207929,"twenty":-44.898573,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-17","current":-5.207929,"twenty":-44.137114,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-24","current":-5.237377,"twenty":-43.29527,"median":8.253213,"eighty":139.458758,"marketCap":796343109},{"date":"2025-01-31","current":-5.241583,"twenty":-42.152128,"median":8.253213,"eighty":139.458758,"marketCap":796982742},{"date":"2025-02-04","current":-5.249997,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"marketCap":798262008}],"updateTime":1774849901061},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDMO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613719394","title":"Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719394","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719394?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934400,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Feb.  24, 2026  (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improveme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243338/0/en/Aquestive-Therapeutics-to-Report-Fourth-Quarter-2025-Financial-Results-and-Recent-Business-Highlights-on-March-4-and-Host-Conference-Call-on-March-5-at-8-00-a-m-ET.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AQST","BK4181","BK4539","BK4144","CDMO","ET","LENZ","BK4218","BK4588","BK4007","HST","BK4139","BK4581","BK4590","BK4561","BK4585"],"gpt_icon":0},{"id":"2613193707","title":"Full year Trading Update and Notice of Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2613193707","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613193707?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934400,"startTime":"0","endTime":"0","summary":"Revenues at the upper end of guidance and pivot to EBITDA profitability - expectations for 2026 unchanged and guidance reiterated Revenues expected to increase c.30% as OXB continues to execute its st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243367/0/en/Full-year-Trading-Update-and-Notice-of-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","CC","NC","BK4098","BK4139","BK4156"],"gpt_icon":0},{"id":"2613209193","title":"Morepen Laboratories Secures INR8.25 Billion CDMO Mandate; Shares Jump 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613209193","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613209193?lang=en_us&edition=fundamental","pubTime":"2026-02-23 13:35","pubTimestamp":1771824903,"startTime":"0","endTime":"0","summary":"Morepen Laboratories  secured a multi-year contract development and manufacturing organization  mandate worth about 8.25 billion Indian rupees from an undisclosed global pharmaceutical company, according to an Indian bourse filing on Monday.Shares of the company jumped over 13% in recent trade.Supplies under the contract are expected to begin within four to five months, with execution planned through the first quarter of the next financial year, subject to operational and regulatory clearances, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2613065782","title":"Morepen Labs Wins ₹825 Crore Global CDMO Mandate to Scale Manufacturing Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2613065782","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613065782?lang=en_us&edition=fundamental","pubTime":"2026-02-23 12:03","pubTimestamp":1771819422,"startTime":"0","endTime":"0","summary":"Morepen Laboratories Limited ( ($IN:MOREPENLAB) ) has shared an update. Morepen Laboratories has secured a multi-year CDMO mandate worth about ₹825...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/morepen-labs-wins-₹825-crore-global-cdmo-mandate-to-scale-manufacturing-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/morepen-labs-wins-₹825-crore-global-cdmo-mandate-to-scale-manufacturing-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2612984446","title":"Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2612984446","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612984446?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:00","pubTimestamp":1771419600,"startTime":"0","endTime":"0","summary":"Expands patent protection across major global pharmaceutical markets, including the U.S., China and Asia-PacificEnablesscalable, automated manufacturing of diverse immune cell therapies using propriet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/18/3240180/11974/en/Pluri-Secures-Global-IP-Position-with-China-Patent-Grant-for-Large-Scale-Immune-Cell-Expansion-Complementing-Prior-U-S-Patent.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1481599808.USD","BK4230","LU1481600234.SGD","CAR","IP","BK4588","CDMO","LU1169589451.USD","BK4585","IE00B3T34201.USD","LU1169590202.USD","LU2463526074.USD","TIL","BK4022","BK4505","BK4139","LU1487256676.USD","BK4136"],"gpt_icon":0},{"id":"2612448600","title":"Press Release: Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2612448600","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612448600?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:00","pubTimestamp":1771416000,"startTime":"0","endTime":"0","summary":"-- Board-certified allergist and leading food allergy and anaphylaxis. WARREN, N.J., Feb. 18, 2026  -- Aquestive Therapeutics, Inc.  , a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm New Drug Application  to the United Stated Food and Drug Administration  and advance its clinical pipeline.Dr. Greenhawt is an internationally recognized expert in allergy and immunology with particular expertise in food allergy, anaphylaxis, patient-centered care, and health services and health policy research. He brings extensive clinical, research, and advocacy experience to Aquestive at a critical juncture in the Company's history.\"Dr. Greenhawt's appointment represents another strong addition to the Aquestive leadership team,\" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","CDMO","BK4007","BK4585","R","BK4588","BK4604","03160","BK4022","BK4099","TM","AQST","LENZ","BK4232","BK4539","BK4139"],"gpt_icon":0},{"id":"2612519064","title":"Press Release: Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm","url":"https://stock-news.laohu8.com/highlight/detail?id=2612519064","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612519064?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:00","pubTimestamp":1771329600,"startTime":"0","endTime":"0","summary":"JERUSALEM, Feb. 17, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.  , a biopharmaceutical company developing inflammation and immunology (I&I) therapeutics and operating a growing CDMO business, today announced that it has acquired 100% of the shares of Recipharm Israel Ltd., which operates Recipharm's site in Yavne, Israel, and entered into a long-term strategic commercial collaboration with Recipharm.The transactions significantly expand Scinai's manufacturing footprint, capabilities, and commercial positioning, strengthening its CDMO platform and creating a differentiated, end-to-end development and manufacturing offering spanning early development directly by Scinai and late-stage clinical and commercial supply by Recipharm. Under the collaboration agreement, development activities and tech transfer will be set up between the companies in a manner designed to facilitate an efficient and frictionless graduation of Scinai clients to Recipharm at the appropriate stage. As a resul","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91348","BK4139","CDMO","SCNI","BK4007"],"gpt_icon":0},{"id":"1133857400","title":"Goldman Sachs: Mainland Healthcare Sector Returns to Hinge on Data and Earnings Visibility This Year, CDMO Firms Favored","url":"https://stock-news.laohu8.com/highlight/detail?id=1133857400","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133857400?lang=en_us&edition=fundamental","pubTime":"2026-02-09 14:17","pubTimestamp":1770617841,"startTime":"0","endTime":"0","summary":"According to a research report from Goldman Sachs, the strong trends observed in the mainland healthcare sector last year are expected to continue into this year. However, investors are increasingly...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","LU1046422090.SGD","06990","BK1589","LU0052750758.USD","LU2125910500.SGD","HK0000306685.HKD","BK1576","BK1191","BK1161","02359","LU0196878994.USD","BK1583","BK4139","LU2488822045.USD","LU2045819591.USD","HK0000320264.USD","SG9999014674.SGD","02696","LU0320764599.SGD","LU0708995583.HKD","02268","HK0000306701.USD","BK1141","HK0000165453.HKD","CDMO","03692","HK0000320223.HKD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2608159822","title":"Bora Pharmaceuticals Unit to Buy CDMO Operational Assets for $18 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2608159822","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608159822?lang=en_us&edition=fundamental","pubTime":"2026-02-03 18:35","pubTimestamp":1770114912,"startTime":"0","endTime":"0","summary":"Bora Pharmaceuticals Co.  unit Bora Pharmaceuticals Inc. agreed to acquire contract development and manufacturing organization  operational assets in Maple Grove, Minnesota, U.S., for $18 million.The assets will be purchased from related party Upsher-Smith Laboratories, according to a Tuesday Taiwan Exchange filing.The transaction is a part of an internal operational restructuring within the group, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2607772997","title":"Press Release: Piramal Pharma Limited Announces Results for Q3 and 9M FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2607772997","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607772997?lang=en_us&edition=fundamental","pubTime":"2026-01-29 13:36","pubTimestamp":1769664960,"startTime":"0","endTime":"0","summary":"MUMBAI, India, Jan. 29, 2026 /CNW/ -- Piramal Pharma Limited  , a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Third Quarter  and Nine Month  ended 31 December 2025.Particulars                     Q3FY26  Q3FY25  YoY %   9MFY26  9MFY25  YoY %. Revenue from Operations          2,140   2,204    %   6,117   6,397    %. Nandini Piramal, Chairperson, Piramal Pharma Limited, said, \"FY26 has been a muted year for the Company due to impact of inventory destocking and slower early-stage order inflows in H1FY26 in our CDMO business. However, in recent time, we are seeing early signs of recovery with pick-up in RFPs and order inflows on the back of improved biopharma funding and increased M&A activities in the US healthcare space. In our CHG business, we are investing in new products and expanding our presence in the ex-US markets. Acquiring niche brand like Kenalog, which is synergetic to our current business, is an i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4221","BK4099","BK4585","R","BK4139","BK4232","PCH","CDMO","BK4084","03160","BK4555","BK4588","BK4604","TM","BK4022"],"gpt_icon":0},{"id":"2605910934","title":"NARMAFOTINIB Large-Scale Manufactre Complete","url":"https://stock-news.laohu8.com/highlight/detail?id=2605910934","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605910934?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:30","pubTimestamp":1769088600,"startTime":"0","endTime":"0","summary":"Successful completion of the first large-scale manufacture of narmafotinib which produced approx. 13 kg of drug Successful transition of process and production from an R&D facility to a commercial man","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/22/3223746/0/en/NARMAFOTINIB-Large-Scale-Manufactre-Complete.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4551","BK4139","INNMF","BK4535","BK4503","BK4023","API"],"gpt_icon":0},{"id":"2605176614","title":"Press Release: Samsung Biologics reports fourth quarter and fiscal year 2025 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2605176614","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605176614?lang=en_us&edition=fundamental","pubTime":"2026-01-21 15:21","pubTimestamp":1768980060,"startTime":"0","endTime":"0","summary":"-- Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW. -- Maintained momentum through consistent operational performance and robust. INCHEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Samsung Biologics , a leading contract development and manufacturing organization , reported financial results for the fourth quarter and fiscal year 2025.Samsung Biologics continued to expand its global CDMO business through long-term partnerships with pharmaceutical companies worldwide. The company secured a KRW 1.1 trillion manufacturing agreement with a European pharmaceutical company in the fourth quarter of 2025, contributing to a cumulative contract value exceeding USD 21 b","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESG","03160","CDP","CDMO","BK4585","BK4223","BK4604","BK4139","BK4555","BK4099","TM","BK4588"],"gpt_icon":0},{"id":"2603647294","title":"Press Release: Biomerica Reports Second Quarter Fiscal 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2603647294","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603647294?lang=en_us&edition=fundamental","pubTime":"2026-01-15 06:17","pubTimestamp":1768429020,"startTime":"0","endTime":"0","summary":"-- Balance Sheet Strengthens and Working Capital Improves by 14.7%. IRVINE, Calif., Jan. 14, 2026  -- Biomerica, Inc. ,  a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fiscal 2026 ended November 30, 2025.a marketing services agreement with Henry Schein to. IBS test in the United States. In addition, inFoods. IBS was featured in a Henry Schein publication highlighting. a precision-based approach to the management of Irritable. and support broader adoption of the test in clinical. The launch of its inFoods IBS Trigger Food Navigator,. The inFoods IBS test identifies, on average,two to four specific foods that trigger a patient's. IBS symptoms, leading to a simple, highly targeted. and actionable dietary plan. The new AI-backed Trigger. Food Navigator builds on this approach by making it. even easier for patients to follow their personalized. established a national Medicare payment rate of $300. patient ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0949170772.SGD","LU2637428348.USD","LU0545039389.USD","BMRA","LU0553294199.USD","LU0738911758.USD","R","LU2346227817.USD","LU1003077747.HKD","TM","BK4555","CMS","LU0661504455.SGD","BK4208","BK4232","BK4022","LU1894683264.USD","BK4082","03160","LU2500361329.USD","CDMO","BK4604","LU1894683348.USD","BK4139","BK4099","ERC","BK4585"],"gpt_icon":0},{"id":"1114069729","title":"Strong Earnings and Acquisition of TOT Biopharm Bolster WUXI XDC's (02268) Position in ADC CDMO Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1114069729","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114069729?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:39","pubTimestamp":1768405156,"startTime":"0","endTime":"0","summary":"On January 14, 2026, WUXI XDC (02268) issued a positive profit alert for its 2025 fiscal year and simultaneously disclosed its launch of a voluntary conditional cash offer to acquire TOT Biopharm....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADC","BK4080","02268","BK1141","BK4231","SG9999014674.SGD","CDMO","LU2488822045.USD"],"gpt_icon":0},{"id":"2603616942","title":"Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616942","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603616942?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:00","pubTimestamp":1768395600,"startTime":"0","endTime":"0","summary":"~ Attendees Invited to Visit Integer at Booth #115 ~PLANO, Texas, Jan.  14, 2026  (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/14/3218551/26755/en/Integer-to-Showcase-Innovations-in-Neuromodulation-Miniaturized-Active-Implantable-Device-Technology-During-NANS-2026-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","BK4139","LU0128526141.USD","LU0566484027.USD","LU1169590202.USD","LU1559883803.SGD","BK4082","LU0029874061.USD","CDMO","ITGR","LU1815336091.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"1192674699","title":"CLSA: WUXI APPTEC (02359) Top Pick in China's Pharma CRO/CDMO Sector, Expected to Outperform Peers This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1192674699","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192674699?lang=en_us&edition=fundamental","pubTime":"2026-01-14 14:32","pubTimestamp":1768372365,"startTime":"0","endTime":"0","summary":"CLSA has released a research report stating that, looking ahead to 2026, it believes profit delivery will be more important than valuation expansion for the Chinese healthcare sector, forecasting...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","BK1583","600056","BK4139","LU2488822045.USD","BK0188","02359","LU0052750758.USD","LU2045819591.USD","BK1576","BK0250","LU2328871848.SGD","LU2495084118.USD","BK1141","LU2242644610.SGD","LU1997245177.USD","LU0456842615.SGD","CDMO","LU1979443071.USD","BK0175","LU1808992512.USD","BK0082","LU1997245094.SGD","LU0708995583.HKD","BK0216","LU1969619763.USD","BK0028","LU1934453819.USD","LU1046422090.SGD","LU2125910500.SGD","BK0010","603259","LU1997244956.HKD","BK0185"],"gpt_icon":0},{"id":"2603656266","title":"Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2603656266","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603656266?lang=en_us&edition=fundamental","pubTime":"2026-01-14 07:34","pubTimestamp":1768347240,"startTime":"0","endTime":"0","summary":"Signing ceremony held during the J.P. Morgan Healthcare Conference. Under the agreement, LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates, supportingRakuten Medical's global clinical development and future commercialization.Rakuten Medical's proprietary photoimmunotherapy technology is designed to selectively target cells in solid tumors, bycombining cell-targeting moieties, such as antibodies,with light-activatable agents, enabling focal and selective destruction of solid tumor cells upon light exposure.","market":"other","thumbnail":"https://mma.prnewswire.com/media/2861266/photo__Rakuten_Medical_and_LOTTE_Biologics_Sign_Manufacturing_Agreement_to_Support_Biopharmaceutica.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2861266/photo__Rakuten_Medical_and_LOTTE_Biologics_Sign_Manufacturing_Agreement_to_Support_Biopharmaceutica.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/rakuten-medical-and-lotte-biologics-sign-manufacturing-agreement-to-support-biopharmaceuticals-in-global-oncology-program-302660416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2595377939","title":"Nutriband CEO Publishes Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2595377939","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595377939?lang=en_us&edition=fundamental","pubTime":"2025-12-31 20:00","pubTimestamp":1767182400,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Dec.  31, 2025  (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on ach","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/31/3211738/0/en/Nutriband-CEO-Publishes-Letter-to-Shareholders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","LU2237443382.USD","IE00BHPRN162.USD","BK4585","BK4604","LU0149725797.USD","LU2237443549.SGD","LU0267386448.USD","LU2237443622.USD","LU2237443895.HKD","LU0882574139.USD","BK4139","BK4007","NTRBW","IE00BFXG1179.USD","TM","IE00BZ1G4Q59.USD","BK4099","CMC","BK4588","LU2237443978.SGD","LU2237443465.HKD","LU0170899867.USD","03160","LU2746668974.SGD","CDMO","NTRB","IND","BK4006","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","LU2746668461.USD","BK4555","LU1363072403.SGD"],"gpt_icon":0},{"id":"2592138133","title":"MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2592138133","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592138133?lang=en_us&edition=fundamental","pubTime":"2025-12-19 08:39","pubTimestamp":1766104740,"startTime":"0","endTime":"0","summary":"- South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM targeting the Japanese knee osteoarthritis market.SEOUL, South Korea, Dec. 19, 2025 /PRNewswire/ -- MEDIPOST Co., Ltd. , a fully integrated cell therapy biotechnology company, today announced a multi-year partnership with Japan's Teikoku Seiyaku Co., Ltd. for the commercialization of CARTISTEM, an innovative treatment for knee osteoarthritis, in the Japanese market.Antonio Seung Jin Lee, Head of MEDIPOST's Global Business Division and Co-CEO of MEDIPOST, Inc. & Akira Nakagawa, Board Member & Senior Managing Director, International Business. In turn, Teikoku Seiyaku Co. Ltd. will leverage its extensive orthopedic hospital and clinic network to promote and distribute CARTISTEM in order to accelerate CARTISTEM's adoption among patients with moderate to severe knee osteoarthritis. Teikoku Seiyaku Co. Ltd. also plans to expand its medical representative d","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2849356/image.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2849356/image.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/medipost-announces-the-exclusive-commercialization-license-agreement-with-teikoku-seiyaku-for-knee-osteoarthritis-treatment-cartistem-in-japan-302646496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2591981666","title":"Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2591981666","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591981666?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:00","pubTimestamp":1765886400,"startTime":"0","endTime":"0","summary":"CHASKA, Minn., Dec.  16, 2025   -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , today announced that the company will participate at the 44th Annual J.P. Morgan Healthcare Conference. The conference will take place January 12-15, 2026, in San Francisco, California. Details regarding Lifecore’s participation are as follows: 44th Annual J.P. Morgan Healthcare ConferenceDetails: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetings Conference Dates: January 12-15, 2026Location: San Francisco, California About Lifecore Biomedical Lifecore Biomedical, Inc.  is a fully integrated contract development and manufacturing organization  that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206095/23089/en/Lifecore-Biomedical-to-Participate-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","BK4588","XLV","BK4121","LU0128526141.USD","LU2271345857.HKD","LU0106831901.USD","BK4137","BK4534","LU1989772923.USD","LU0795875169.SGD","LU0795875086.SGD","LU2028103732.USD","LU0006306889.USD","IE00BKVL7J92.USD","LU1668664300.SGD","XBI","LU0234570918.USD","LU2111349929.HKD","LU0106261372.USD","LU0314104364.USD","LU0158827948.USD","LU1732800096.USD","CFO","LU1162221912.USD","BK4585","LU0971096721.USD","LU0225283273.USD","LU2089284900.SGD","CDMO","LU1720051017.SGD","BK4139","LABU","LU0528227936.USD","LU1244550221.USD","LU0557290698.USD","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU1791710400.SGD","LU0158827781.USD","LU2347655156.SGD","LU0029874061.USD","BK4504","LU2089283258.USD","BK4581","LFCR","LU0912757837.SGD","LU1720051108.HKD","LU1363072403.SGD","HCSG"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":75,"code":"91000000","status":"200"}]}}